Adherence to 5-Alpha Reductase Inhibitor Therapy For Benign Prostatic Hyperplasia: Clinical and Economic Outcomes
2012
Objective:
Our goal was to quantify relationships between adherence to 5-alpha reductase inhibitors (5-ARIs), the risk of acute urinary retention (AUR) and prostate surgery, and medical costs related to patients with benign prostatic hyperplasia (BPH).
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
15
References
6
Citations
NaN
KQI